about
Structural evolution of the BRCA1 genomic region in primates.Distinct effects of ligand-induced PDGFRα and PDGFRβ signaling in the human rhabdomyosarcoma tumor cell and stroma cell compartments.The Hippo effector TAZ (WWTR1) transforms myoblasts and TAZ abundance is associated with reduced survival in embryonal rhabdomyosarcoma.Dual blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) pathways synergistically inhibits rhabdomyosarcoma cell growth in vitro and in vivo.MicroRNA and gene co-expression networks characterize biological and clinical behavior of rhabdomyosarcomas.Impact of fusion gene status versus histology on risk-stratification for rhabdomyosarcoma: Retrospective analyses of patients on UK trials.Fusion gene addiction: can tumours be forced to give up the habit?Immunohistochemical detection of glypican-5 in paraffin-embedded material: an optimized method for a novel research antibody.Antitumor activity of sustained N-myc reduction in rhabdomyosarcomas and transcriptional block by antigene therapy.Glypican-3 is expressed in rhabdomyosarcomas but not adult spindle cell and pleomorphic sarcomas.Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: an approach to identify candidate genes involved in tumor development.Endosialin expression in soft tissue sarcoma as a potential marker of undifferentiated mesenchymal cells.IGF1R signalling in testicular germ cell tumour cells impacts on cell survival and acquired cisplatin resistance.The Hippo transducer YAP1 transforms activated satellite cells and is a potent effector of embryonal rhabdomyosarcoma formation.IGF signalling in germ cells and testicular germ cell tumours: roles and therapeutic approaches
P50
Q34366192-659804FE-2C12-48A5-AF47-ED58C0AEEF3BQ36903863-12FE533D-6FCB-4DBB-8F8A-1080082C972BQ37199465-06BE29B7-0FE9-4A78-86D9-D91C36E4D1D6Q37281508-9F526DCE-55A8-42DD-8CA8-DD6C7FC45785Q38725853-D269073E-629E-4B18-B301-DCB18A97C596Q38776314-CF5C221C-C21E-49B1-8691-7FE968777ECAQ38853922-5AE7D5C6-0322-4B22-B8FF-4F39FF62A2A8Q39380349-766DBC09-1CB8-40F4-81EC-3A13AF3769D9Q39446630-B1321D4A-6EA7-4499-B6D3-A84C4226EBCBQ39760480-2CDF145C-8793-4636-B282-C4D02350B05BQ39880703-A99EF811-35AA-40B0-BCC7-5497778D49ABQ42269585-50375CA9-B71F-447F-8B93-D5F591012FB7Q48262511-33AD76EF-8010-4FAA-B08D-8D1FF9D92F18Q53029961-9E7C0513-182E-4E81-9E2D-EF9A4B6394D5Q92622946-DF9EA3DE-00DB-4157-8770-A88B926A3EB2
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Joanna Selfe
@ast
Joanna Selfe
@en
Joanna Selfe
@es
Joanna Selfe
@nl
type
label
Joanna Selfe
@ast
Joanna Selfe
@en
Joanna Selfe
@es
Joanna Selfe
@nl
prefLabel
Joanna Selfe
@ast
Joanna Selfe
@en
Joanna Selfe
@es
Joanna Selfe
@nl
P106
P31
P496
0000-0002-9556-3628